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Background: Obesity is associated with insulin resistance, development of diabetes, and coronary heart disease. There is
limited information on the contribution of previous obesity on the risk of coronary heart disease. We aimed to examine
the effect of previous history of obesity on the occurrence of coronary heart disease in patients with diabetes.
Methods: We carried out a retrospective chart analysis of 315 type 2 diabetic patients without obesity and without
atherosclerotic cardiovascular events at their initial hospital visit (men/women 236/79; mean ± standard deviation; age
53.1 ± 6.6 years; maximal body mass index before enrollment (MAXBMI) 26.6 ± 3.4 kg/m2; decrease of the BMI at
enrollment from MAXBMI (deltaBMI) 4.23 ± 2.62 kg/m2) to investigate the association of previous obesity (MAXBMI larger
than 30 kg/m2) with the long-term incidence of cardiovascular events. Of 315 patients, forty-eight were previously obese.
Results: After median follow-up of 13.9 years, 48 patients developed coronary heart disease. The Kaplan-Meier analysis
exhibited that coronary heart disease occurred more frequently in previously obese patients than in subjects in the
reference category (22 kg/m2 < or = MAXBMI < 25 kg/m2) and that the effect lasted proportionally over follow-up
periods. Multivariate Cox regression models showed that hazard ratios and corresponding 95% confidence intervals of
coronary heart disease for patients with previous obesity compared with subjects in the reference category were 2.52
and 1.15 to 5.50 (p value = 0.020) after adjustment for age, sex, smoking status, systolic blood pressure, total cholesterol
and HDL cholesterol. In this cohort, deltaBMI strongly correlated with MAXBMI and also behaved as a risk factor. The
hazard ratios and 95% confidence intervals by the increment of one standard deviation of deltaBMI after adjustment for
age, sex, smoking status, systolic blood pressure, total cholesterol and HDL cholesterol were 1.38 and 1.08 to 1.79
(p value = 0.013).
Conclusions: Previous obesity and/or large body weight loss before admission might act as an increased risk for
coronary heart disease.
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The accelerated Westernization of lifestyles has led to a
rapid increase in the number of type 2 diabetic patients
worldwide, to the extent that diabetes has now been rec-
ognized as a threat to public health. In patients with type
2 diabetes (T2DM), a high prevalence of cardiovascular* Correspondence: rithonda@hosp.ncgm.go.jp
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distribution, and reproduction in any mediumdiseases is observed at a relatively young age [1]. Thus,
risk factors for atherosclerosis must be evaluated in pa-
tients with T2DM.
Obesity is frequently associated with insulin resistance,
development of diabetes [2,3], and atherosclerotic cardio-
vascular disease [1,4,5]. The body mass index (BMI) of
Japanese has been reported to increase until the age
group of 60-69 [6,7] and a BMI larger than 27.5 was associ-
ated with an increased risk of myocardial infarction [8].
In patients with T2DM, past obesity might be overlooked
because those who had previously been overweight/obeseed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of the reason why subjects classed as normal-weight at
the time of incident diabetes showed non-significant
but higher rates of cardiovascular mortality than subjects
who were classed as overweight/obese at the time of inci-
dent diabetes [10].
Previously obese diabetic patients were likely to be as-
sociated with higher burden of atherosclerosis [11,12],
but the long-term risk comparison of coronary heart dis-
ease between previously obese diabetic patients and
never obese diabetic patients has not been examined in
detail. The aim of the present study was to examine the
effect of overweight/obesity before their first visit to a
hospital on the long-term occurrence of coronary heart
disease in patients with T2DM.
Methods
Population for analysis
This study was a part of the retrospective cohort follow-
up study of T2DM. A total of 560 subjects with the diag-
nosis of T2DM visited a hospital located in the center of
Tokyo between 1987 and 1992 [13,14]. Of the 560 sub-
jects, we selected 430 subjects (age under 65 years). We
excluded patients aged over 65 years in the present ana-
lysis because about one-third of the patients in this age
group had already experienced cardiovascular events at
their first visit to the hospital. Of the 430 subjects, an
additional 61 subjects were excluded from the present
analyses because of the poor quality of their medical re-
cords, leaving 369 subjects. We next excluded another
49 subjects with coronary heart disease or stroke at the
time of their first visit to the hospital, leaving 320 sub-
jects. We finally selected 315 non-obese subjects (236
men and 79 women) for enrollment in the present ana-
lysis. Since their first visit to the hospital, the patients
were encouraged to reduce and maintain their BMI at a
value under 22 kg/m2, to walk 10,000 steps a day, and
to consume a low-fat (less than 30% of the daily caloric
intake), low-energy (25 – 27 kcal/ideal body weight/
day) diet. Intake ratios of saturated fatty acids, mono-
saturated fatty acids, and polyunsaturated fatty acids of
3: 4: 3 were recommended.
Study variables
We retrospectively evaluated the charts of the 315 pa-
tients from the first visit to the hospital (the study’s
starting point) to the occurrence of coronary heart dis-
ease (the study’s endpoint) or January 2004, whichever
came first.
We obtained the patients’ medical records including
smoking status (never smoker, ex-smoker or smoker at
enrollment) and their weight history (self-reported max-
imal body weight and the age at which patients reached
their maximal body weight) and examined their BMI,systolic and diastolic blood pressure, serum total chol-
esterol levels (determined enzymatically), triglyceride
levels (determined enzymatically), HDL-cholesterol level
(determined using the deposition method), and glyco-
sylated hemoglobin (HbA1c) level. MAXBMI (maximal
body mass index before enrollment) was calculated as:
[self-reported maximal weight before enrollment (kg)]/
[height at enrollment (m)]2. The HbA1c level was deter-
mined using high-performance liquid chromatography
using HLC-723GHb II (Tosoh, Tokyo) at enrollment. The
HbA1c values measured using HLC-723GHb II were cali-
brated to a National Glycohemoglobin Standardization
Program value (%) [15]. The LDL-cholesterol level was cal-
culated according to the Friedewald equation [16]. The
diagnosis of coronary heart disease (coronary insufficiency
and myocardial infarction) was made according to criteria
defined by the Framingham Heart Study [17]. The diagno-
sis of myocardial infarction was determined by specified
electrocardiographic changes accompanied by an elevation
of serum enzymes. Coronary insufficiency was defined as
prolonged ischemic chest pain accompanied by transient
ischemic abnormalities on electrocardiography. Coronary
angiography was performed in all patients of suspicious
coronary heart disease and a diagnosis of coronary heart
disease was confirmed by narrowed or blocked coronary
arteries. This research program conformed to the ethical
recommendations for epidemiologic studies, as declared by
the Ministry of Health, Labour and Welfare in Japan, and
was approved by the National Center for Global Health
and Medicine Research Ethics Committee.
Statistical analysis
The data analysis was performed using R [18]. The con-
tinuous variables were summarized as mean ± standard
deviation or median with 25th-75th percentiles (for vari-
ables not showing normal distribution). For analysis, we
grouped MAXBMI as follows: 18.5 to less than 22, 22 to
less than 25 (reference category), 25 to less than 27.5,
27.5 to less than 30, and 30 or greater. There were no
patients whose MAXBMI was less than 18.5. The Kaplan-
Meier method was used to estimate survival curves of
cardiovascular events associated with the MAXBMI cat-
egory. The log-rank test was used to compare the
unadjusted survival curves. Multivariate Cox regression
models were used to examine the interaction of known




Mean age ± standard deviation of the 315 patients was
53.1 ± 6.6 years, mean MAXBMI ± standard deviation
was 26.6 ± 3.4 kg/m2, and mean BMI at enrollment ±
standard deviation was 22.4 ± 2.7 kg/m2.
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vascular events at the start point, 48 of them developed
coronary heart disease. Twenty-seven patients died with-
out experiencing coronary heart disease and 168 were
continuing to visit the hospital without having experi-
enced coronary heart disease. Seventy-two patients had
stopped visiting the hospital before January 2004 without
having experienced coronary heart disease. The median
observation period from the start of the observation to
the endpoint was 13.9 years. The characteristics of the
315 patients at the start of the observation period are
summarized in Table 1. Forty-eight had history of obes-
ity. Ten of them had become obese before the age of
thirty and another twenty of them had become obese be-
fore the age of forty.
At enrollment, patients with a MAXBMI greater than
or equal to 30 kg/m2 had a larger BMI than patients
with a MAXBMI less than 30 kg/m2. Patients with a
MAXBMI greater than or equal to 30 kg/m2 had higher
HbA1c and lower HDL cholesterol values, but the differ-
ence was not statistically significant. Patients with a
MAXBMI greater than or equal to 30 kg/m2 had a
higher incidence of diabetic retinopathy than patients withTable 1 Mean values or prevalence of factors at baseline of th
Less than
22.0
22.0 to less t
(referen
Number of patients (men/women) 22 (15/7) 84 (63/
Age (years) 52.4 ± 5.6 53.4 ±
Observation period (years) 14.5 ± 3.6 12.6 ±
Ex/present smokers (%) 22.7/45.5 28.6/27
MAXBMI (kg/m2) 21.0 ± 0.86§ 23.7 ± 0
DeltaBMI (kg/m2) 2.17 ± 1.38§ 3.21 ± 1
Time interval between MAXBMI and BMI
at enrollment (years)
8.5 (4–14.5) 15 (6–1
BMI at enrollment (kg/m2) 18.9 ± 1.7* 20.5 ±
HbA1c (%) 9.2 ± 1.8 9.2 ± 2
Medications for hyperglycemia
OHA (%) 45.5 40.5
Insulin (%) 22.7 11.9
Total cholesterol (mmol/L) 5.54 ± 0.86 5.37 ± 1
HDL cholesterol (mmol/L) 1.47 ± 0.45* 1.20 ± 0
LDL cholesterol (mmol/L) 3.52 ± 0.88 3.49 ± 1
Triglyceride (mmol/L) 1.34 ± 0.66 1.81 ± 1
Systolic blood pressure (mmHg) 130.9 ± 18.5 128.0 ±
Diastolic blood pressure (mmHg) 77.0 ± 10.1 75.7 ± 1
Medications for hypertension (%) 0.0 6.0
Diabetic retinopathy (%) 22.7 27.7
Values are presented as a percentage (%), as means ± SD, or as median with 25th-75th
Abbreviations: BMI, body mass index; MAXBMI, maximal body mass index before enra MAXBMI less than 30 kg/m2. This result was consistent
with the report of Ogawa et al. [11].
The Kaplan-Meier analysis
The Kaplan-Meier analysis exhibited that coronary heart
disease occurred more frequently in previously obese
patients and that the effect seemed proportional over
the follow-up periods (Figure 1B; MAXBMI compared
with subjects in the reference category for the log-rank
statistic; p = 0.0029). After stratification by gender, cor-
onary heart disease occurred more frequently both in
men and in women, but the results with women did not
reach significance (Figure 1C and 1D). The occurrence of
coronary heart disease of previously overweight patients
was comparable to that of never-overweight patients
(Figure 1B). In addition, the occurrence of coronary heart
disease was not affected by BMI category at enrollment
(Figure 1A).
Cox regression models
Next we used Cox regression models to examine the
interaction of known risk factors as confounding factors




25.0 to less than
27.5




21) 95 (80/15) 66 (48/18) 48 (31/17)
7.5 52.8 ± 6.3 53.5 ± 6.7 53.3 ± 6.2
5.4 12.3 ± 5.9 11.9 ± 5.6 11.4 ± 5.1
.4 30.5/40.0 36.3/33.3 14.6/39.6
.77 26.2 ± 0.65§ 28.5 ± 0.66§ 32.6 ± 2.12§
.68 3.47 ± 1.81 4.89 ± 2.13§ 7.63 ± 3.13§
5) 8.5 (4–15) † 9 (3.5-16.5)* 15 (10–22)
1.7 22.8 ± 1.9§ 23.6 ± 2.2§ 25.0 ± 2.7§
.0 9.0 ± 2.1 9.8 ± 2.0 9.9 ± 2.1
49.5 42.4 47.9
8.4 12.1 14.6
.33 5.23 ± 0.99 5.60 ± 1.14 5.60 ± 1.18
.34 1.14 ± 0.30 1.11 ± 0.26 1.10 ± 0.28
.28 3.24 ± 0.92 3.64 ± 1.03 3.57 ± 0.97
.78 2.06 ± 1.54 2.07 ± 1.40 2.24 ± 1.59
20.1 128.9 ± 17.4 131.2 ± 17.9 132.6 ± 18.5
2.1 79.3 ± 10.7 80.2 ± 9.7 78.7 ± 12.6
17.9 12.1 8.3
20.0 36.4 50.0§
percentiles; * P < 0.05, † P < 0.01, § P < 0.001 versus the reference category.
ollment; deltaBMI, decrease of the BMI at enrollment from MAXBMI.
Figure 1 Kaplan-Meier survival curves from the probability of remaining free of coronary heart disease events. A: categorized by the
body mass index (BMI) at enrollment, B: categorized by the maximal body mass index before enrollment (MAXBMI), C: categorized by the
maximal body mass index before enrollment (MAXBMI) with diabetic men, D: categorized by the maximal body mass index before enrollment
(MAXBMI) with diabetic women.
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threshold effect rather than a graded increase of MAXBMI,
suggesting unrecognized factors acted with regard to previ-
ous obesity. Hazard ratios and corresponding 95% confi-
dence intervals of coronary heart disease for patients with
previous obesity compared with subjects in the reference
category (22 < or = MAXBMI < 25) were 2.52 and 1.15 to
5.50 (p value = 0.020) after adjustment for age and sex with
additional adjustment for smoking status, serum lipids,
and blood pressure (Table 2).
In the present cohort, a larger decrease of BMI before
enrollment was observed in patients with larger MAXBMI
(Table 1). The differences between BMI at enrollment and
MAXBMI (deltaBMI) strongly correlated with MAXBMI
values (Pearson’s correlation coefficient = 0.64) and
deltaBMI also related with the occurrence of coronary
heart disease. The hazard ratios by the increment of onestandard deviation of deltaBMI (2.62 kg/m2) were calcu-
lated as 1.38 (95% confidence intervals: 1.08 to 1.79;
p value = 0.013) after adjustment for age, sex, smoking
status, serum lipids, and blood pressure (Table 3). The
association became weak after adjustment for HbA1c at
enrollment (Table 3), suggesting that prolonged poor gly-
cemic control was in part related to the patients with a
large deltaBMI.
Discussion
In the present cohort where deltaBMI strongly corre-
lated with MAXBMI, we could not distinguish which of
the two, namely a threshold value of previous obesity or
a graded relationship of preceding weight loss before en-
rollment, behaved as principal risk factor. In order to
find out which of the two (or both) behaved as a princi-
pal risk factor, other cohorts in which there were weaker
Table 2 Cox proportional hazards regression analysis with maximal body mass index before enrollment
Maximal body mass index before enrollment (MAXBMI, kg/m2)
Less than 22.0 22.0 - 24.9 (reference) 25.0 - 27.4 27.5 – 29.9 30.0 or greater
Model 1 HR (95% CI) 0.90 (0.25-3.24) P = 0.87 1.00 0.85 (0.36-2.01) P = 0.70 0.98 (0.39-2.44) P = 0.96 2.78 (1.28-6.01) P = 0.009
Model 2 HR (95% CI) 1.07 (0.29-4.00) P = 0.92 1.00 0.90 (0.38-2.17) P = 0.82 0.96 (0.39-2.42) P = 0.94 2.52 (1.15-5.50) P = 0.020
Model 3 HR (95% CI) 1.00 (0.27-3.73) P = 0.99 1.00 0.94 (0.39-2.24) P = 0.88 0.94 (0.37-2.36) P = 0.90 2.31 (1.05-5.08) P = 0.038
Analysis was performed to estimate hazard ratios (HR) with corresponding 95% confidence intervals (95% CI) for coronary heart disease associated with maximal
body mass index before enrollment (MAXBMI).
Reference categories were subjects with a MAXBMI between 22.0 and 24.9.
Model 1 is adjusted for age and sex; model 2, model 1 plus smoking status, systolic blood pressure, total cholesterol and HDL cholesterol; model 3, model 2 plus
HbA1c values at enrollment.
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examined.
Obesity exacerbated atherosclerosis before enrollment
by way of the classical cardiovascular risk factors and
other factors such as high serum levels of lipoprotein
(a), increased oxidative stress, and low-grade inflamma-
tion [19,20]. Accelerated atherosclerosis was more often
observed in previously obese T2DM patients than in
never-obese T2DM patients [11,12]. With the best possible
medical care including the control of blood pressure and
serum LDL cholesterol levels after enrollment, atheroscler-
osis progressed to coronary heart disease in previously
obese patients. Factors such as persistent dysfunction of
HDL including cholesterol efflux capacity, and persistent
low-grade inflammation might play roles to progression of
atherosclerosis even after weight reduction [21-24]. The
degree of visceral fat reduction was well correlated with
alteration of both inflammatory and anti-inflammatory
cytokine levels, while the degree of visceral fat reduction
in response to weight reduction varied from patient to
patient [25].
A large amount of weight loss due to persistent
hyperglycemia or accelerated atherosclerosis [26] in-
duced sarcopenia with reduction of gynoid fat [27-29],
resulting in features of so-called “normal weight obesity” orTable 3 Cox proportional hazards regression analysis
with differences between BMI at enrollment and MAXBMI
(deltaBMI)
Model 1
HR (95% CI) per 1 SD 1.35 (1.03 - 1.72) P = 0.029
Model 2
HR (95% CI) per 1 SD 1.38 (1.08 - 1.79) P = 0.013
Model 3
HR (95% CI) per 1 SD 1.31 (0.99 – 1.70) P = 0.057
Analysis was performed to estimate the hazard ratios (HR) with the
corresponding 95% confidence intervals (95% CI) for coronary heart disease
associated with the differences between BMI at enrollment and
MAXBMI (deltaBMI).
Model 1 is adjusted for age and sex; model 2, model 1 plus smoking status,
systolic blood pressure, total cholesterol and HDL cholesterol; model 3, model 2
plus HbA1c values at enrollment.“metabolically obese individual” at enrollment [30]. Ele-
vated risks for coronary heart disease were also ob-
served with short-term, unintentional weight loss in
middle adulthood [31].
We admit that the present study has several additional
limitations. The most important limitation is that we do
not have data about waist circumferences, body fat content,
daily physical activity and inflammatory parameters such
as CRP, fibrinogen, or proinflammatory cytokines of the
participants at enrollment, nor could we examine the result
of body weight loss on body composition of the partici-
pants. Second, the patients recruited in the study were
from a single hospital in the center of Tokyo and many of
the patients were businesspersons. After admission, blood
glucose, blood pressure and serum LDL cholesterol levels
were under control by medication if necessary, so that the
effect of obesity on these risk factors might be cancelled.
Thus, replication studies including other cohorts living
under different life styles with a different treatment strategy
of diabetes are warranted. Third, due to the small numbers
(only one-quarter of the sample, 78 cases) of women pa-
tients at enrollment, we could not conclude the risk of
“previously obese” diabetic women. Finally, survival biases
might play a role. Patients classed as normal-weight at the
time of incident diabetes were reported to show higher
rates of overall mortality than subjects who were classed as
overweight/obese at the time of incident diabetes [10].
Conclusions
Obesity before enrollment and/or large body weight loss
before the admission acted as a life-long risk factor for
coronary heart disease in patients with T2DM. In clinical
practice, it is advisable to ask patients with T2DM what
their previous maximal body weight was, and to calcu-
late their MAXBMI and deltaBMI to estimate cardiovas-
cular risk. From the epidemiological point of view, it is
advisable to avoid obesity in young adults to reduce the
risk of developing diabetes [32,33] as well as to reduce
the risk for coronary heart disease [34,35]. It is also ad-
visable to advise patients to undergo a medical check-up
every year so as not to leave diabetes undiagnosed, un-
treated, or left poorly controlled.
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